Free Trial

Groupama Asset Managment Buys 1,593 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Synopsys logo with Computer and Technology background

Groupama Asset Managment boosted its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 36.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,968 shares of the semiconductor company's stock after buying an additional 1,593 shares during the quarter. Groupama Asset Managment's holdings in Synopsys were worth $3,022,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Davidson Capital Management Inc. grew its stake in Synopsys by 33,828.6% in the 3rd quarter. Davidson Capital Management Inc. now owns 4,750 shares of the semiconductor company's stock valued at $2,405,000 after purchasing an additional 4,736 shares during the period. Swiss National Bank lifted its holdings in Synopsys by 0.7% during the third quarter. Swiss National Bank now owns 454,800 shares of the semiconductor company's stock valued at $230,306,000 after purchasing an additional 3,200 shares during the last quarter. Parnassus Investments LLC bought a new position in Synopsys during the third quarter worth about $633,469,000. Harvest Portfolios Group Inc. boosted its holdings in Synopsys by 3.7% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 42,121 shares of the semiconductor company's stock worth $21,330,000 after buying an additional 1,496 shares during the period. Finally, Jacobs & Co. CA bought a new position in Synopsys in the 3rd quarter worth approximately $10,554,000. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Price Performance

SNPS traded up $1.99 on Monday, hitting $517.28. The company had a trading volume of 2,336,524 shares, compared to its average volume of 1,073,896. Synopsys, Inc. has a 52-week low of $457.52 and a 52-week high of $629.38. The stock has a fifty day simple moving average of $529.93 and a 200-day simple moving average of $544.69. The firm has a market capitalization of $79.46 billion, a P/E ratio of 35.63, a P/E/G ratio of 3.25 and a beta of 1.08.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Mizuho assumed coverage on Synopsys in a report on Tuesday, October 22nd. They set an "outperform" rating and a $650.00 target price for the company. Robert W. Baird lowered their price target on Synopsys from $644.00 to $630.00 and set an "outperform" rating on the stock in a report on Thursday. Rosenblatt Securities reaffirmed a "buy" rating and issued a $635.00 target price on shares of Synopsys in a research note on Wednesday, December 4th. Needham & Company LLC reissued a "buy" rating and issued a $640.00 price target on shares of Synopsys in a report on Thursday. Finally, JPMorgan Chase & Co. increased their target price on Synopsys from $655.00 to $685.00 and gave the company an "overweight" rating in a research note on Thursday, August 22nd. One analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $649.00.

Read Our Latest Report on Synopsys

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Articles

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should you invest $1,000 in Synopsys right now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines